Table 2.
Relationship between age and clinical trial understanding (n=74)
| Age; n (%) | ||||
|---|---|---|---|---|
| <65 | ≥65 | Chi-Square | P value | |
| To cure the patients in the clinical trial | 3.65 | .16 | ||
| Yes | 12 (26.7) | 5 (17.2) | ||
| No | 21 (46.7) | 10 (34.5) | ||
| I don’t know | 12 (26.7) | 14 (48.3) | ||
| To reduce as much as possible the lymphoma of patients in the trial | 7.56 | .023 | ||
| Yes | 29 (64.4) | 13 (44.8) | ||
| No | 10 (22.2) | 4 (13.8) | ||
| I don’t know | 6 (13.3) | 12 (41.4) | ||
| To keep the lymphoma of patients in the trial from getting worse | 8.16 | .017 | ||
| Yes | 28 (62.2) | 14 (48.3) | ||
| No | 11 (24.4) | 3 (10.3) | ||
| I don’t know | 6 (13.3) | 12 (41.4) | ||
| To advance research on treatments for indolent lymphoma | 1.05 | .59 | ||
| Yes | 40 (88.9) | 25 (86.2) | ||
| No | 1 (2.2) | 0 (0) | ||
| I don’t know | 4 (8.9) | 4 (13.8) | ||